DOI QR코드

DOI QR Code

Reduced aggregation of the leghorn male hepatoma cell line in suspension by supplementing dextran sulfate in the media

  • Jung Soo Lim (Division of Biological Science and Technology, Yonsei University) ;
  • Ji Soo Kim (Division of Biological Science and Technology, Yonsei University) ;
  • Yugyeong Cheon (Division of Biological Science and Technology, Yonsei University) ;
  • Tae Sub Park (Graduate School of International Agricultural Technology and Institute of Green-Bio Science and Technology, Seoul National University) ;
  • Jong Kwang Hong (Division of Biological Science and Technology, Yonsei University)
  • Received : 2024.05.30
  • Accepted : 2024.08.22
  • Published : 2025.02.01

Abstract

Objective: The study aimed to improve the efficiency of leghorn male hepatoma (LMH) cells for animal virus vaccine production by transitioning from adherent to suspension culture and evaluating the effects of dextran sulfate (DS) on preventing cell aggregation. The goal was to enhance cell growth, viability, and glucose metabolism and to develop efficient suspension-adapted LMH cells for large-scale vaccine production. Methods: LMH cells previously cultured in an adherent state were transferred to 125 mL Erlenmeyer flasks to conduct suspension culture. Cell culture performance, including cell density, viability, and glucose metabolism, during the cultures was measured, along with an assessment of cell aggregation. Additionally, mRNA expression levels of genes associated with cell adhesion and apoptosis were monitored. Results: DS supplementation in suspension culture enhanced cell viability and growth, with higher cell densities and viabilities compared to control media. Additionally, DS supplementation reduced glucose consumption and waste production, indicating improved metabolic efficiency. DS also delayed cell aggregation, possibly by downregulating integrin expression and promoting anti-apoptotic gene expression. However, even after 2 months, cell aggregation persisted in both control and DS-supplemented cultures, suggesting further optimization is needed for LMH cell adaptation to suspension culture. Conclusion: DS supplementation in LMH cell suspension cultures led to notable improvements in cell growth, viability, and glucose metabolism, while also decreasing the cell aggregation.

Keywords

References

  1. Zhu J. Mammalian cell protein expression for biopharmaceutical production. Biotechnol Adv 2012;30:1158-70. https://doi.org/10.1016/j.biotechadv.2011.08.022 
  2. Kim JY, Kim YG, Lee GM. CHO cells in biotechnology for production of recombinant proteins: current state and further potential. Appl Microbiol Biotechnol 2012;93:917-30. https://doi.org/10.1007/s00253-011-3758-5
  3. Montomoli E, Khadang B, Piccirella S, et al. Cell culture-derived influenza vaccines from Vero cells: a new horizon for vaccine production. Expert Rev Vaccines 2014;11:587-94. https://doi.org/10.1586/erv.12.24 
  4. Aubrit F, Perugi F, Leon A, et al. Cell substrates for the production of viral vaccines. Vaccine 2015;33:5905-12. https://doi.org/10.1016/j.vaccine.2015.06.110
  5. Genzel Y. Designing cell lines for viral vaccine production: where do we stand? Biotechnol J 2015;10:728-40. https://doi.org/10.1002/biot.201400388
  6. Tan E, Chin CSH, Lim ZFS, Ng SK. HEK293 Cell line as a platform to produce recombinant proteins and viral vectors. Front Bioeng Biotechnol 2021;9:796991. https://doi.org/10.3389/fbioe.2021.796991 
  7. Kunitake R, Suzuki A, Ichihashi H, Matsuda S, Hirai O, Morimoto K. Fully-automated roller bottle handling system for large scale culture of mammalian cells. J Biotechnol 1997;52:289-94. https://doi.org/10.1016/S0168-1656(96)01654-9
  8. Chu L, Robinson DK. Industrial choices for protein production by large-scale cell culture. Curr Opin Biotechnol 2001;12:180-7. https://doi.org/10.1016/S0958-1669(00)00197-X
  9. Werner RG, Walz F, Noé W, Konrad A. Safety and economic aspects of continuous mammalian cell culture. J Biotechnol 1992;22:51-68. https://doi.org/10.1016/0168-1656(92)90132-S 
  10. Shen CF, Guilbault C, Li X, et al. Development of suspension adapted vero cell culture process technology for production of viral vaccines. Vaccine 2019;37:6996-7002. https://doi.org/10.1016/j.vaccine.2019.07.003 
  11. Park S, Kim JY, Ryu KH, et al. Production of a foot-and-mouth disease vaccine antigen using suspension-adapted bhk-21 cells in a bioreactor. Vaccines 2021;9:505. https://doi.org/10.3390/vaccines9050505 
  12. Meissner P, Pick H, Kulangara A, Chatellard P, Friedrich K, Wurm FM. Transient gene expression: recombinant protein production with suspension-adapted HEK293-EBNA cells. Biotechnol Bioeng 2001;75:197-203. https://doi.org/10.1002/bit.1179 
  13. Lee N, Shin J, Park JH, Lee GM, Cho S, Cho BK. Targeted gene deletion using DNA-free RNA-guided Cas9 nuclease accelerates adaptation of cho cells to suspension culture. ACS Synth Biol 2016;5:1211-9. https://doi.org/10.1021/acssynbio.5b00249 
  14. Condreay LD, Aldrich CE, Coates L, Mason WS, Wu TT. Efficient duck hepatitis B virus production by an avian liver tumor cell line. J Virol 1990;64:3249-58. https://doi.org/10.1128/jvi.64.7.3249-3258.1990 
  15. Li T, Xie J, Lv L, et al. A chicken liver cell line efficiently supports the replication of ALV-J possibly through its high level viral receptor and efficient protein expression system. Vet Res 2018;49:41. https://doi.org/10.1186/s13567-018-0537-7 
  16. Lee CW, Jung K, Jadhao SJ, Suarez DL. Evaluation of chickenorigin (DF-1) and quail-origin (QT-6) fibroblast cell lines for replication of avian influenza viruses. J Virol Methods 2008;153:22-8. https://doi.org/10.1016/j.jviromet.2008.06.019 
  17. Khanna M, Kumar P, Choudhary K, Kumar B, Vijayan VK. Emerging influenza virus: a global threat. J Biosci 2008;33:475-82. https://doi.org/10.1007/s12038-008-0066-z 
  18. Hammond TG, Hammond JM. Optimized suspension culture: the rotating-wall vessel. Am J Physiol Renal Physiol 2001;281:F12-25. https://doi.org/10.1152/ajprenal.2001.281.1.F12 
  19. Ryu JH, Kim MS, Lee GM, Choi CY, Kim BS. The enhancement of recombinant protein production by polymer nanospheres in cell suspension culture. Biomaterials 2005;26:2173-81. https://doi.org/10.1016/j.biomaterials.2004.06.017 
  20. van Wielink R, Kant-Eenbergen HCM, Harmsen MM, Martens DE, Wijffels RH, Coco-Marrtin JM. Adaptation of a Madin–Darby canine kidney cell line to suspension growth in serumfree media and comparison of its ability to produce avian influenza virus to Vero and BHK21 cell lines. J Virol Methods 2011;171:53-60. https://doi.org/10.1016/j.jviromet.2010.09.029 
  21. Rourou S, Ben Zakkour M, Kallel H. Adaptation of Vero cells to suspension growth for rabies virus production in different serum free media. Vaccine 2019;37:6987-95. https://doi.org/10.1016/j.vaccine.2019.05.092 
  22. Renner WA, Jordan M, Eppenberger HM, Leist C. Cell–cell adhesion and aggregation: Influence on the growth behavior of CHO cells. Biotechnol Bioeng 1993;41:188-93. https://doi.org/10.1002/bit.260410204 
  23. Pais DAM, Carrondo MJT, Alves PM, Teixeira AP. Towards real-time monitoring of therapeutic protein quality in mammalian cell processes. Curr Opin Biotechnol 2014;30:161-7. https://doi.org/10.1016/j.copbio.2014.06.019 
  24. Wu S, Rish AJ, Skomo A, Zhao Y, Drennen JK, Anderson CA. Rapid serum-free/suspension adaptation: medium development using a definitive screening design for Chinese hamster ovary cells. Biotechnol Prog 2021;37:e3154. https://doi.org/10.1002/btpr.3154 
  25. Zanghi JA, Renner WA, Bailey JE, Fussenegger M. The growth factor inhibitor suramin reduces apoptosis and cell aggregation in protein-free CHO cell batch cultures. Biotechnol Prog 2000;16:319-25. https://doi.org/10.1021/bp0000353 
  26. Li L, Qin J, Feng Q, et al. Heparin promotes suspension adaptation process of CHO–TS28 cells by eliminating cell aggregation. Mol Biotechnol 2011;47:9-17. https://doi.org/10.1007/s12033-010-9306-1 
  27. Ritacco FV, Wu Y, Khetan A. Cell culture media for recombinant protein expression in Chinese hamster ovary (CHO) cells: history, key components, and optimization strategies. Biotechnol Prog 2018;34:1407-26. https://doi.org/10.1002/btpr.2706 
  28. Sarrazin S, Lamanna WC, Esko JD. Heparan sulfate proteoglycans. Cold Spring Harb Perspect Biol 2011;3:a004952. https://doi.org/10.1101/cshperspect.a004952 
  29. Dee KU, Shuler ML, Wood HA. Inducing single-cell suspension of BTI-TN5B1-4 insect cells: I. the use of sulfated polyanions to prevent cell aggregation and enhance recombinant protein production. Biotechnol Bioeng 1997;54:191-205. https://doi.org/https://doi.org/10.1002/(SICI)1097-0290(19970505)54:3<191::AID-BIT1>3.0.CO;2-A 
  30. Tsao YS, Condon R, Schaefer E, Lio P, Liu Z. Development and improvement of a serum-free suspension process for the production of recombinant adenoviral vectors using HEK293 cells. Cytotechnology 2001;37:189-98. https://doi.org/10.1023/A:1020555310558 
  31. Tsuyoshi T, Chouhei S, Shuichi KIN, et al. Dextran sulfate suppresses cell adhesion and cell cycle progression of melanoma cells. Anticancer Res 2005;25:895-902. 
  32. Wu H, Tang X, Wang Y, et al. Dextran sulfate prevents excess aggregation of human pluripotent stem cells in 3D culture by inhibiting ICAM1 expression coupled with down-regulating E-cadherin through activating the Wnt signaling pathway. Stem Cell Res Ther 2022;13:218. https://doi.org/10.1186/s13287-022-02890-4 
  33. Saisud S, Posung M, Tuntigumthon S, Areesirisuk A, Dhepakson P, Teeka J. Development of an animal-derived component-free medium for Spodoptera frugiperda (Sf9) cells using response surface methodology. Biotechnol Lett 2023;45:761-77. https://doi.org/10.1007/s10529-023-03389-5 
  34. Park JH, Lim MS, Woo JR, Kim JW, Lee GM. The molecular weight and concentration of dextran sulfate affect cell growth and antibody production in CHO cell cultures. Biotechnol Prog 2016;32:1113-22. https://doi.org/10.1002/btpr.2287 
  35. Reinhart D, Damjanovic L, Kaisermayer C, Kunert R. Benchmarking of commercially available CHO cell culture media for antibody production. Appl Microbiol Biotechnol 2015;99:4645-57. https://doi.org/10.1007/s00253-015-6514-4 
  36. Pereira S, Kildegaard HF, Andersen MR. Impact of CHO metabolism on cell growth and protein production: an overview of toxic and inhibiting metabolites and nutrients. Biotechnol J 2018;13:1700499. https://doi.org/10.1002/biot.201700499 
  37. Bokel C, Brown NH. Integrins in development: moving on, responding to, and sticking to the extracellular matrix. Dev Cell 2002;3:311-21.  https://doi.org/10.1016/S1534-5807(02)00265-4
  38. Theocharis AD, Skandalis SS, Gialeli C, Karamanos NK. Extracellular matrix structure. Adv Drug Deliv Rev 2016;97:4-27. https://doi.org/10.1016/j.addr.2015.11.001 
  39. Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest 2009;119:1420-8. https://doi.org/10.1172/JCI39104 
  40. Huhn S, Chang M, Kumar A, et al. Chromosomal instability drives convergent and divergent evolution toward advantageous inherited traits in mammalian CHO bioproduction lineages. iScience 2022;25:104074. https://doi.org/10.1016/j.isci.2022.104074 
  41. van der Valk J, Brunner D, De Smet K, et al. Optimization of chemically defined cell culture media-replacing fetal bovine serum in mammalian in vitro methods. Toxicol In Vitro 2010;24:1053-63. https://doi.org/10.1016/j.tiv.2010.03.016 
  42. Jang M, Pete ES, Bruheim P. The impact of serum-free culture on HEK293 cells: From the establishment of suspension and adherent serum-free adaptation cultures to the investigation of growth and metabolic profiles. Front Bioeng Biotechnol 2022;10:964397. https://doi.org/10.3389/fbioe.2022.964397 
  43. Arthuso FS, Bartolini P, Soares CR. Laboratory production of human prolactin from CHO cells adapted to serum-free suspension culture. Appl Biochem Biotechnol 2012;167:2212-24. https://doi.org/10.1007/s12010-012-9745-1